China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note released on Monday morning. The brokerage issued a hold rating on the stock. China Pharma Price Performance China Pharma stock opened at $0.09 on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.82 and […]

Leave a Reply

Your email address will not be published.

Previous post Bank of America Lowers ChargePoint (NYSE:CHPT) to Neutral
Next post StockNews.com Begins Coverage on PolyMet Mining (NYSEAMERICAN:PLM)